Katrina Altersitz Wells

Gisborne

Vice President, Editorial Features at Healio

Vice President, Editorial Features at Healio Aesthetics

Vice President, Editorial Features at Healio Dermatology

Editor working in gastro/hep and creating my own path after receiving my #BRCA1 diagnosis http://t.co/4IlVNkrtJ2

Featured in: Favicon

healio.com

Articles

Healio | HemOnc Today announces 2025 Disruptive Innovators

3 weeks ago | healio.com | Katrina Altersitz Wells

CHICAGO — Healio | HemOnc Today hosted its fourth Disruptive Innovators Awards ceremony, crowning nine new winners at ASCO Annual Meeting. Co-hosted by Shikha Jain, MD, FACP, founder of Women in Medicine, and Ed S. Kim, MD, of City of Hope, these awards honor those in the hematology/oncology space who are positively disrupting the field and pushing the status quo to improve clinical practice.
Time to vote: Healio | HemOnc Today announce 2025 Disruptive Innovators nominees

Mar 7, 2025 | healio.com | Edward Kim |Shikha Jain |Eleonora Teplinsky |Katrina Altersitz Wells

Healio | HemOnc Today is excited to announce the nominees for its annual Disruptive Innovators Awards in oncology and hematology. Individuals who changed the face of the specialty and pushed the status quo toward betterment of the field will be recognized during a live event at ASCO Annual Meeting. In this video, awards ceremony co-hosts Shikha Jain, MD, FACP, and Edward S.
Weight loss linked to lower inflammatory markers in women with breast cancer

Dec 15, 2024 | healio.com | Katrina Altersitz Wells

You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. SAN ANTONIO — Weight loss via lifestyle intervention showed correlation to improved inflammatory markers in a group of women with HER2-negative breast cancer, according to a presenter here. Jennifer A.
Combination treatment shows promise in

Dec 14, 2024 | healio.com | Katrina Altersitz Wells

You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. SAN ANTONIO — Combining a poly(ADP-ribose) polymerase inhibitor with a PD-1 antibody in a nonchemotherapy regimen for BRCA-mutated breast cancer showed promise, according to a presenter here. Erica L.
Researchers seek to improve the 'diagnostic odyssey' of infant biliary atresia evaluations

Nov 27, 2024 | healio.com | Erin Michael |Katrina Altersitz Wells

You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways A new ultrasound approach helped identify patients later diagnosed with biliary atresia. The method would provide a quicker, less invasive approach that would not require fasting.
Noninvasive risk scoring system shows promise in predicting PSC progression

Nov 26, 2024 | healio.com | Katrina Altersitz Wells |Heather Biele

You've successfully added Liver/Biliary Disorders to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected].
‘Do your due diligence’ in cases of suspected, recurrent hepatic encephalopathy

Oct 29, 2024 | healio.com | Katrina Altersitz Wells |Heather Biele

You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected].
Identifying, treating alcohol-associated liver disease in women requires change in mindset

Oct 28, 2024 | healio.com | Katrina Altersitz Wells |Heather Biele

You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. PHILADELPHIA — The rate of alcohol-associated liver disease among women is the rise and physicians must keep it in mind when discussing medical history with their female patients, according to a review presented here.
From 300 patients to 1,600, City of Hope remains at the forefront of cell therapy

Oct 25, 2024 | healio.com | Katrina Altersitz Wells |Mindy Valcarcel

You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. When Healio | Cell Therapy Next visited City of Hope in 2019, the institute boasted a robust cell therapy program, having treated 300 patients with the then-newly approved therapy.
Looking back, looking forward: Penn’s CAR-T program continues path of progress

Aug 28, 2024 | healio.com | Katrina Altersitz Wells |Mindy Valcarcel

You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. In 2018, at the height of the chimeric antigen receptor T-cell therapy revolution and in the heart of its implementation, Healio’s Cell Therapy Next staff went onsite to University of Pennsylvania’s newly minted center.